朗科科技(300042.SZ):韶關朗正工廠成立運營時間較短 各項業務處於拓展前期
格隆匯4月8日丨朗科科技(300042.SZ)在投資者互動平台表示,目前公司在韶關共有兩座工廠,其中韶關朗科半導體有限公司(簡稱“韶關朗科”)為公司主要產品生產基地,各項生產活動正常,能滿足公司訂單需求。韶關朗正數據半導體有限公司(簡稱“朗正工廠”)系公司在加深產業鏈上游擴張與合作上佈局封測領域成立的合資公司,工廠於2023年8月開業運營,目前朗正工廠正常開展業務中,生產則根據訂單情況合理安排,近期由於晶圓與已封裝存儲顆粒升幅倒掛等因素,基於集團整體成本效益考慮,集團直接採購了成本更低的存儲顆粒。韶關朗正工廠成立運營時間較短,各項業務處於拓展前期,業務量佔集團總體業務的比重較小。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.